Cargando…

Non-Omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves SARS-CoV-2 BA.4/5 neutralization

The immune responses to SARS-CoV-2 variants in COVID-19 cases are influenced by various factors including pre-existing immunity via vaccination and prior infection. Elucidating the drivers for upgrading neutralizing activity to SARS-CoV-2 in COVID-19 cases with pre-existing immunity will aid in impr...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyamoto, Sho, Arashiro, Takeshi, Ueno, Akira, Kanno, Takayuki, Saito, Shinji, Katano, Harutaka, Iida, Shun, Ainai, Akira, Ozono, Seiya, Hemmi, Takuya, Hirata, Yuichiro, Moriyama, Saya, Kotaki, Ryutaro, Kinoshita, Hitomi, Yamada, Souichi, Shinkai, Masaharu, Fukushi, Shuetsu, Takahashi, Yoshimasa, Suzuki, Tadaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837220/
https://www.ncbi.nlm.nih.gov/pubmed/36687316
http://dx.doi.org/10.1016/j.isci.2023.105969
_version_ 1784869029820760064
author Miyamoto, Sho
Arashiro, Takeshi
Ueno, Akira
Kanno, Takayuki
Saito, Shinji
Katano, Harutaka
Iida, Shun
Ainai, Akira
Ozono, Seiya
Hemmi, Takuya
Hirata, Yuichiro
Moriyama, Saya
Kotaki, Ryutaro
Kinoshita, Hitomi
Yamada, Souichi
Shinkai, Masaharu
Fukushi, Shuetsu
Takahashi, Yoshimasa
Suzuki, Tadaki
author_facet Miyamoto, Sho
Arashiro, Takeshi
Ueno, Akira
Kanno, Takayuki
Saito, Shinji
Katano, Harutaka
Iida, Shun
Ainai, Akira
Ozono, Seiya
Hemmi, Takuya
Hirata, Yuichiro
Moriyama, Saya
Kotaki, Ryutaro
Kinoshita, Hitomi
Yamada, Souichi
Shinkai, Masaharu
Fukushi, Shuetsu
Takahashi, Yoshimasa
Suzuki, Tadaki
author_sort Miyamoto, Sho
collection PubMed
description The immune responses to SARS-CoV-2 variants in COVID-19 cases are influenced by various factors including pre-existing immunity via vaccination and prior infection. Elucidating the drivers for upgrading neutralizing activity to SARS-CoV-2 in COVID-19 cases with pre-existing immunity will aid in improving COVID-19 booster vaccines with enhanced cross-protection against antigenically distinct variants, including the Omicron sub-lineage BA.4/5. This study revealed that the magnitude and breadth of neutralization activity to SARS-CoV-2 variants after breakthrough infections are determined primarily by upper respiratory viral load and vaccination-infection time interval. Extensive neutralizing breadth, covering even the most antigenically distant BA.4/5, was observed in cases with higher viral load and longer time intervals. Antigenic cartography depicted a critical role of the time interval in expanding the breadth of neutralization to SARS-CoV-2 variants. Our results illustrate the importance of dosing interval optimization as well as antigen design in developing variant-proof booster vaccines.
format Online
Article
Text
id pubmed-9837220
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-98372202023-01-17 Non-Omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves SARS-CoV-2 BA.4/5 neutralization Miyamoto, Sho Arashiro, Takeshi Ueno, Akira Kanno, Takayuki Saito, Shinji Katano, Harutaka Iida, Shun Ainai, Akira Ozono, Seiya Hemmi, Takuya Hirata, Yuichiro Moriyama, Saya Kotaki, Ryutaro Kinoshita, Hitomi Yamada, Souichi Shinkai, Masaharu Fukushi, Shuetsu Takahashi, Yoshimasa Suzuki, Tadaki iScience Article The immune responses to SARS-CoV-2 variants in COVID-19 cases are influenced by various factors including pre-existing immunity via vaccination and prior infection. Elucidating the drivers for upgrading neutralizing activity to SARS-CoV-2 in COVID-19 cases with pre-existing immunity will aid in improving COVID-19 booster vaccines with enhanced cross-protection against antigenically distinct variants, including the Omicron sub-lineage BA.4/5. This study revealed that the magnitude and breadth of neutralization activity to SARS-CoV-2 variants after breakthrough infections are determined primarily by upper respiratory viral load and vaccination-infection time interval. Extensive neutralizing breadth, covering even the most antigenically distant BA.4/5, was observed in cases with higher viral load and longer time intervals. Antigenic cartography depicted a critical role of the time interval in expanding the breadth of neutralization to SARS-CoV-2 variants. Our results illustrate the importance of dosing interval optimization as well as antigen design in developing variant-proof booster vaccines. Elsevier 2023-01-13 /pmc/articles/PMC9837220/ /pubmed/36687316 http://dx.doi.org/10.1016/j.isci.2023.105969 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Miyamoto, Sho
Arashiro, Takeshi
Ueno, Akira
Kanno, Takayuki
Saito, Shinji
Katano, Harutaka
Iida, Shun
Ainai, Akira
Ozono, Seiya
Hemmi, Takuya
Hirata, Yuichiro
Moriyama, Saya
Kotaki, Ryutaro
Kinoshita, Hitomi
Yamada, Souichi
Shinkai, Masaharu
Fukushi, Shuetsu
Takahashi, Yoshimasa
Suzuki, Tadaki
Non-Omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves SARS-CoV-2 BA.4/5 neutralization
title Non-Omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves SARS-CoV-2 BA.4/5 neutralization
title_full Non-Omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves SARS-CoV-2 BA.4/5 neutralization
title_fullStr Non-Omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves SARS-CoV-2 BA.4/5 neutralization
title_full_unstemmed Non-Omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves SARS-CoV-2 BA.4/5 neutralization
title_short Non-Omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves SARS-CoV-2 BA.4/5 neutralization
title_sort non-omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves sars-cov-2 ba.4/5 neutralization
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837220/
https://www.ncbi.nlm.nih.gov/pubmed/36687316
http://dx.doi.org/10.1016/j.isci.2023.105969
work_keys_str_mv AT miyamotosho nonomicronbreakthroughinfectionwithhigherviralloadandlongervaccinationinfectionintervalimprovessarscov2ba45neutralization
AT arashirotakeshi nonomicronbreakthroughinfectionwithhigherviralloadandlongervaccinationinfectionintervalimprovessarscov2ba45neutralization
AT uenoakira nonomicronbreakthroughinfectionwithhigherviralloadandlongervaccinationinfectionintervalimprovessarscov2ba45neutralization
AT kannotakayuki nonomicronbreakthroughinfectionwithhigherviralloadandlongervaccinationinfectionintervalimprovessarscov2ba45neutralization
AT saitoshinji nonomicronbreakthroughinfectionwithhigherviralloadandlongervaccinationinfectionintervalimprovessarscov2ba45neutralization
AT katanoharutaka nonomicronbreakthroughinfectionwithhigherviralloadandlongervaccinationinfectionintervalimprovessarscov2ba45neutralization
AT iidashun nonomicronbreakthroughinfectionwithhigherviralloadandlongervaccinationinfectionintervalimprovessarscov2ba45neutralization
AT ainaiakira nonomicronbreakthroughinfectionwithhigherviralloadandlongervaccinationinfectionintervalimprovessarscov2ba45neutralization
AT ozonoseiya nonomicronbreakthroughinfectionwithhigherviralloadandlongervaccinationinfectionintervalimprovessarscov2ba45neutralization
AT hemmitakuya nonomicronbreakthroughinfectionwithhigherviralloadandlongervaccinationinfectionintervalimprovessarscov2ba45neutralization
AT hiratayuichiro nonomicronbreakthroughinfectionwithhigherviralloadandlongervaccinationinfectionintervalimprovessarscov2ba45neutralization
AT moriyamasaya nonomicronbreakthroughinfectionwithhigherviralloadandlongervaccinationinfectionintervalimprovessarscov2ba45neutralization
AT kotakiryutaro nonomicronbreakthroughinfectionwithhigherviralloadandlongervaccinationinfectionintervalimprovessarscov2ba45neutralization
AT kinoshitahitomi nonomicronbreakthroughinfectionwithhigherviralloadandlongervaccinationinfectionintervalimprovessarscov2ba45neutralization
AT yamadasouichi nonomicronbreakthroughinfectionwithhigherviralloadandlongervaccinationinfectionintervalimprovessarscov2ba45neutralization
AT shinkaimasaharu nonomicronbreakthroughinfectionwithhigherviralloadandlongervaccinationinfectionintervalimprovessarscov2ba45neutralization
AT fukushishuetsu nonomicronbreakthroughinfectionwithhigherviralloadandlongervaccinationinfectionintervalimprovessarscov2ba45neutralization
AT takahashiyoshimasa nonomicronbreakthroughinfectionwithhigherviralloadandlongervaccinationinfectionintervalimprovessarscov2ba45neutralization
AT suzukitadaki nonomicronbreakthroughinfectionwithhigherviralloadandlongervaccinationinfectionintervalimprovessarscov2ba45neutralization